Genetic Targeting Core

基因靶向核心

• 批准号: 10469427
• 负责人: Edita Navratilova
• 金额: $ 37.3万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-08-15 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10469427
• 关键词: Amygdaloid structure; Anatomy; Animals; Applications Grants; Area; Basal Ganglia; Behavioral; Brain; Brain region; CRISPR/Cas technology; Cannabinoids; Capsid; Cells; Chronic; Collaborations; Complex; Corticotropin-Releasing Hormone; Cre driver; Data; Development; Dopamine; Drug usage; Drug user; Dynorphins; Endocannabinoids; Engineering; Ensure; Experimental Designs; Future; G-Protein-Coupled Receptors; Gene Deletion; Gene Delivery; Gene Mutation; Gene Targeting; Genes; Genetic; Genetic Materials; Genetic Techniques; Genome; Glutamates; Goals; Habits; Halorhodopsins; Immunohistochemistry; Impairment; Individual; Investigation; Ion Channel; Knowledge; Light; Methodology; Methods; Microscopy; Modernization; Mus; National Institute of Drug Abuse; Neurons; Neurotransmitters; Non-Viral Vector; Norepinephrine; Opioid; Opioid Peptide; Opsin; Outcome; Outcome Measure; Peripheral Nervous System; Pharmaceutical Preparations; Phase; Plasmid Cloning Vector; Plasmids; Prevention strategy; Property; Proteins; Protocols documentation; Rattus; Relapse; Reporter; Reproducibility; Research; Research Personnel; Resources; Rewards; Rodent; Role; Serotonin; Services; Signal Pathway; Specificity; Standardization; Stress; Substance Use Disorder; System; Techniques; Technology; Transduction Gene; Transfection; Transgenes; Transgenic Mice; Transgenic Organisms; Viral; Viral Vector; Visualization; Withdrawal; Work; addiction; base; brain circuitry; cell type; design; designer receptors exclusively activated by designer drugs; executive function; genetic approach; improved; in vivo; inducible gene expression; innovation; instrument; microbial; neural circuit; neuromechanism; neurotransmission; novel; optogenetics; overexpression; prevent; relating to nervous system; restoration; substance use treatment; tool; transgene expression

Project Summary – Genetic Targeting Core Substance use disorders (SUD) are characterized by dysregulation of brain circuitry that involves diminished activity of the brain reward circuits, increased responsiveness of the stress circuits and impaired functioning of the executive cortical circuits. Neural changes are observed in the basal ganglia, extended amygdala and prefrontal cortical regions and encompass a wide range of endogenous neurotransmitters including dopamine, opioid peptides, endocannabinoids, corticotropin releasing factor (CRF), dynorphin, glutamate and others. It implies that these maladaptations may be causally responsible for behavioral changes often observed in chronic drug users, for example habit formation and compulsive drug taking, that further worsen the neuronal and behavioral signs of SUD. Restoration of normal functioning of the brain circuits is therefore a desirable goal of SUD therapies. However, the exact influence of chronic drug use on the addiction brain circuits and how manipulation of these circuits could prevent or treat substance use disorders remains to be elucidated. As part of the Center of Excellence in Addiction Studies, the Genetic Targeting Core (GT Core) will assist users in obtaining preliminary data on neural mechanisms of addiction that will form basis for future NIDA grant applications. The GT Core will provide services to target and manipulate the addiction circuits in a cell specific and circuits specific manner using state-of-the-art genetic techniques, including optogenetics, chemogenetics and CRISPR/Cas9 gene editing. Optogenetic strategies use microbial-based light activated ion channels (opsins) that allow fast neuronal activation (channelrhodopsins) or inhibition (halorhodopsins, archaerhodopsins), while chemogenetic approaches use engineered ion channels (PSAMs) or G protein- coupled receptors (DREADDs) that can be activated pharmacologicaly. CRISPR/Cas9 gene editing allows direct in vivo manipulation of the genome in rodents. The introduction of functional transgenes, such as opsins and DREADDs or editing of native genes requires in vivo delivery and expression of genetic material in desired cells. This is accomplished with viral or nonviral vector systems. Cell and circuit specificity can be further enhanced by the use of a specific Cre-driver mouse line. The GT Core will provide three main services to its users that correspond with the three Specific Aims: 1) assist with the selection of gene targeting methods, including the choice of the transgenic mouse line, and the type of viral vector; 2) optimize and implement gene delivery using high precision stereotaxic instruments; and 3) verify the efficacy of gene targeting using fluorescent microscopy or protein and gene quantification techniques. The GT Core will coordinate work with the Administrative, Behavioral and Neuroanalytical Cores to develop effective experimental strategies that involve several Cores. The close collaboration between our Cores ensures high expertise in all areas of the addiction research and will permit establishment of standardized outcome measures emphasizing scientific rigor and reproducibility.

项目摘要-基因靶向核心 物质使用障碍（SUD）的特征是脑回路失调， 大脑奖励回路的活动，压力回路的反应性增加， 执行皮层回路在基底神经节、延伸杏仁核和 前额叶皮层区域并包括广泛的内源性神经递质包括多巴胺， 阿片肽、内源性大麻素、促肾上腺皮质激素释放因子（CRF）、强啡肽、谷氨酸等。它 这意味着这些适应不良可能是造成行为变化的原因，经常观察到的慢性 吸毒者，例如习惯形成和强迫性吸毒，这进一步恶化了神经元和 SUD的行为迹象。因此，恢复大脑回路的正常功能是一个理想的目标， SUD疗法。然而，慢性药物使用对成瘾大脑回路的确切影响以及如何影响成瘾大脑回路的确切影响。 操纵这些回路可以预防或治疗物质使用障碍仍有待阐明。 作为成瘾研究卓越中心的一部分，遗传靶向核心（GT核心）将帮助用户 获得成瘾神经机制的初步数据，这将成为未来NIDA拨款的基础。 应用. GT核心将提供服务，以靶向和操纵特定细胞中的成瘾回路。 和电路特定的方式使用最先进的遗传技术，包括光遗传学，化学遗传学， CRISPR/Cas9基因编辑光遗传学策略使用基于微生物的光激活离子通道 （视蛋白）允许快速神经元激活（通道视紫红质）或抑制（盐视紫红质， 古视紫红质），而化学发生方法使用工程化离子通道（PSAMs）或G蛋白- 偶联受体（DREADD），其可被药理学激活。CRISPR/Cas9基因编辑允许直接 在啮齿类动物体内进行基因组操作。引入功能性转基因，如视蛋白和 DREADD或天然基因的编辑需要遗传物质在所需细胞中的体内递送和表达。 这是用病毒或非病毒载体系统完成的。细胞和回路特异性可以通过以下方式进一步增强： 使用特定的Cre-driver鼠标线。 GT Core将为用户提供三项主要服务，与三个特定目标相对应：1）协助 随着基因打靶方法的选择，包括转基因小鼠品系的选择， 病毒载体; 2）使用高精度立体定位仪器优化和实施基因递送;以及3）验证 使用荧光显微镜或蛋白质和基因定量技术进行基因靶向的功效。的 GT核心将与行政、行为和神经分析核心协调工作， 涉及多个核心的实验策略。我们的核心之间的密切合作确保了高 在成瘾研究的所有领域的专业知识，并将允许建立标准化的结果措施 强调科学的严谨性和可重复性。